Cardiovascular Benefits of Commuter Cycling
Not Applicable
Completed
- Conditions
- cardiovascular diseasehypertensionadiposity
- Registration Number
- ACTRN12617000123347
- Lead Sponsor
- niversity of Otago; School of Physical Education
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 28
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie cardiovascular improvements from commuter cycling in ACTRN12617000123347?
How does commuter cycling compare to standard exercise prescriptions for hypertension management?
What biomarkers correlate with enhanced cardiovascular fitness in cycling interventions for adiposity?
What adverse events are associated with sustained commuter cycling in adults with cardiovascular risk factors?
How do aerobic exercise interventions like cycling influence endothelial function and atherosclerosis progression?